Bob Huang

Bob Huang

Directeur/Membre du Conseil chez Travecta Therapeutics Pte Ltd.

Consumer Services
Technology Services
Finance

Provenance du réseau au premier degré de Bob Huang

EntitéType d'entitéIndustrie
8
Holding Company Packaged Software 8
Seidler Equity Australia
3
Subsidiary Investment Managers 3

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Bob Huang via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
ALLERGAN, INC. Pharmaceuticals: Major

June Bray

General Counsel

NEKTAR THERAPEUTICS Pharmaceuticals: Major

Ivan Philip Gergel

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Pascal Heberling

Director/Board Member

Investment Banks/Brokers

Pascal Heberling

Private Equity Investor

Chemicals: Major Diversified

Charles Ryan

Chief Executive Officer

REALM THERAPEUTICS PLC Pharmaceuticals: Major

Ivan Philip Gergel

Director/Board Member

Rotman School of Management College/University

Pascal Heberling

Masters Business Admin

NEUROTROPE, INC. Pharmaceuticals: Major

Ivan Philip Gergel

Charles Ryan

Director/Board Member

Chief Executive Officer

Investment Managers

Pascal Heberling

Private Equity Investor

Miscellaneous Commercial Services

Pascal Heberling

Director/Board Member

Hospital/Nursing Management

Pascal Heberling

Director/Board Member

Investment Managers

Pascal Heberling

Private Equity Investor

University of Rhode Island College/University

June Bray

Undergraduate Degree

Investment Managers

Eustache Besançon

Private Equity Investor

Publishing: Books/Magazines

Pascal Heberling

Director/Board Member

Investment Managers

Dan Murray

Private Equity Investor

Fairleigh Dickinson University College/University

June Bray

Masters Business Admin

University of Toronto College/University

Pascal Heberling

Graduate Degree

Western New England University College/University

Charles Ryan

Director/Board Member

The University of Sydney College/University

Conrad Brown

Undergraduate Degree

Financial Conglomerates

Bruno de Pampelonne

Corporate Officer/Principal

Sciences Po College/University

Pascal Heberling

Undergraduate Degree

Miscellaneous Commercial Services

Charles Ryan

Corporate Officer/Principal

Investment Managers

Bruno de Pampelonne

Founder

Financial Conglomerates

Bruno de Pampelonne

Corporate Officer/Principal

Other Consumer Services

Eustache Besançon

Director/Board Member

Hospital/Nursing Management

Charles Ryan

Corporate Officer/Principal

Pharmaceuticals: Major

Ivan Philip Gergel

Corporate Officer/Principal

Investment Banks/Brokers

Bruno de Pampelonne

Corporate Officer/Principal

École des Hautes Études Commerciales du Nord College/University

Bruno de Pampelonne

Chairman

Berlex Laboratories, Inc.

June Bray

General Counsel

SYNAPTOGENIX, INC. Pharmaceuticals: Major

Ivan Philip Gergel

Charles Ryan

Director/Board Member

Chief Executive Officer

IREIT GLOBAL Real Estate Investment Trusts

Bruno de Pampelonne

Director/Board Member

Real Estate Investment Trusts

Bruno de Pampelonne

Director/Board Member

QUINCE THERAPEUTICS, INC. Biotechnology

Charles Ryan

June Bray

President

Director/Board Member

UCL Medical School College/University

Ivan Philip Gergel

Doctorate Degree

Investment Managers

Bruno de Pampelonne

Director/Board Member

Investment Managers

Pascal Heberling

Private Equity Investor

EDHEC Business School (United Kingdom) College/University

Bruno de Pampelonne

Chairman

Investment Managers

Bruno de Pampelonne

Chief Executive Officer

Miscellaneous Commercial Services

Eustache Besançon

Director/Board Member

Biotechnology

Ivan Philip Gergel

Chairman

BIOXCEL THERAPEUTICS, INC. Biotechnology

June Bray

Director/Board Member

Biotechnology

Charles Ryan

Director/Board Member

Tikehau Investment Management Japan K K Investment Managers

Bruno de Pampelonne

Director/Board Member

PETROS PHARMACEUTICALS Pharmaceuticals: Major

Ivan Philip Gergel

Charles Ryan

Director/Board Member

Chief Executive Officer

ORGANON & CO. Pharmaceuticals: Major

June Bray

General Counsel

65 Equity Partners Management (UK) Ltd. Investment Managers

Pascal Heberling

Private Equity Investor

Credit Suisse First Boston (Singapore) Ltd.

Bruno de Pampelonne

Chief Executive Officer

Statistiques

Internationale

Etats-Unis 24
Royaume-Uni 9
France 8
Singapour 6
Canada 3

Sectorielle

Finance 17
Health Technology 14
Consumer Services 13
Commercial Services 5
Health Services 3

Opérationnelle

Director/Board Member 43
Corporate Officer/Principal 11
Private Equity Investor 10
Independent Dir/Board Member 8
Chief Executive Officer 7
  1. Bourse
  2. Insiders
  3. Bob Huang
  4. Connexions Sociétés